A study published in the European Heart Journal on Feb. 18 suggests healthcare expenditures in Europe would skyrocket if local systems adopted experts’ latest guidelines for cholesterol-lowering treatment.

Women who have suffered domestic abuse are 31% more likely to develop heart disease and 51% more likely to develop type 2 diabetes than women who haven’t been abused, a study out of the U.K. has found.

Many Americans who can’t afford prescription insulin for their diabetes are turning to unregulated, illegal markets for discounted products, researchers reported in JAMA Internal Medicine this month.

Some 20% of children have high blood pressure, WBAL-TV reported Feb. 17.

Stroke survivors who are optimistic about their recovery demonstrate lower levels of inflammation and physical disability than their less-cheerful counterparts, researchers reported at the Nursing Symposium of the American Stroke Association’s International Stroke Conference.

A 92.6% reduction in the list price of tafamidis—an effective but ultimately unaffordable drug designed to treat transthyretin amyloid cardiomyopathy—would be required to make the medication accessible to the average heart patient, researchers reported in Circulation Feb. 12.

A Canadian clinical psychologist is repurposing a beta-blocker to ease the pain of emotional trauma, the BBC reports.

Philips is launching a new randomized controlled trial—dubbed DEFINE GPS—to assess patient outcomes after PCI guided by instant wave-Free Ratio measurements and angiograms.